Patients with mucous membrane pemphigoid need multidisciplinary monitoring

Media contributions

• Title	Patients with mucous membrane pemphigoid need multidisciplinary monitoring
  Degree of recognition	International
  Media name/outlet	Healio
  Media type	Web
  Date	18/07/2022
  Description	“Mucous membrane pemphigoid (MMP) comprises a group of heterogeneous, autoimmune blistering diseases, with predominant mucosal involvement, characterized by autoantibodies directed against structural proteins — including bullous pemphigoid (BP) 180, BP230, laminin-332, type VII collagen and alpha6 and B4 integrin subunits — in the epidermal basement membrane zone,” Hanan Rashid, MD, of the department of dermatology at the Center of Blistering Diseases and the department of pathology at the University of Groningen, both in Groningen, the Netherlands, and colleagues wrote.
  Producer/Author	Rebecca L. Forand
  URL	https://www.healio.com/news/dermatology/20220718/patients-with-mucous-membrane-pemphigoid-need-multidisciplinary-monitoring
  Persons	Hanan Rashid